Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daniel Dugin"'
Autor:
Sandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, Arlene Hurley, Angela Lombardo, Zhiwei Chen, Soe Than, Phumla Adesanya, Catherine Bunce, Mark Boaz, Rosanne Boyle, Eddy Sayeed, Lorna Clark, Daniel Dugin, Claudia Schmidt, Yang Song, Laura Seamons, Len Dally, Martin Ho, Carol Smith, Martin Markowitz, Josephine Cox, Dilbinder K Gill, Jill Gilmour, Michael C Keefer, Patricia Fast, David D Ho
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8617 (2010)
We conducted a Phase I dose escalation trial of ADVAX, a DNA-based candidate HIV-1 vaccine expressing Clade C/B' env, gag, pol, nef, and tat genes. Sequences were derived from a prevalent circulating recombinant form in Yunnan, China, an area of high
Externí odkaz:
https://doaj.org/article/ba21b6228383420b93b1fcfdfb199a37
Autor:
Sandhya Vasan, Sarah J Schlesinger, Zhiwei Chen, Arlene Hurley, Angela Lombardo, Soe Than, Phumla Adesanya, Catherine Bunce, Mark Boaz, Rosanne Boyle, Eddy Sayeed, Lorna Clark, Daniel Dugin, Mar Boente-Carrera, Claudia Schmidt, Qing Fang, LeiBa, Yaoxing Huang, Gerasimos J Zaharatos, David F Gardiner, Marina Caskey, Laura Seamons, Martin Ho, Len Dally, Carol Smith, Josephine Cox, Dilbinder Gill, Jill Gilmour, Michael C Keefer, Patricia Fast, David D Ho
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8816 (2010)
We conducted a Phase I dose-escalation trial of ADMVA, a Clade-B'/C-based HIV-1 candidate vaccine expressing env, gag, pol, nef, and tat in a modified vaccinia Ankara viral vector. Sequences were derived from a prevalent circulating HIV-1 recombinant
Externí odkaz:
https://doaj.org/article/25b6bfc4047d47d09e9a293a9d14fcdd
Autor:
Drew Hannaman, Harriet Park, Mar Boente-Carrera, Patricia E. Fast, Robert M. Bernard, Roselle Vittorino, Lorna Clark, Marina Caskey, David D. Ho, Sarah J. Schlesinger, Jakub Kopycinski, Jill Gilmour, Josephine H. Cox, Carol Smith, David F. Gardiner, Yaoxing Huang, C. Schmidt, Daniel Dugin, Tony Tarragona-Fiol, Johanne Andersen, Dilbinder K. Gill, Arlene Hurley, Hannah Cheeseman, Len Dally, Sandhya Vasan
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 5, p e19252 (2011)
PLoS ONE, Vol 6, Iss 5, p e19252 (2011)
Background: DNA-based vaccines have been safe but weakly immunogenic in humans to date. Methods and Findings: We sought to determine the safety, tolerability, and immunogenicity of ADVAX, a multigenic HIV-1 DNA vaccine candidate, injected intramuscul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fdafabdd1671486a07382d679d4ad3a
http://europepmc.org/articles/PMC3095594
http://europepmc.org/articles/PMC3095594
Autor:
Carol Smith, C. Schmidt, Mar Boente-Carrera, Marina Caskey, Rosanne Boyle, Catherine A. Bunce, Len Dally, David F. Gardiner, Dilbinder K. Gill, Zhiwei Chen, Sandhya Vasan, Qing Fang, Lorna Clark, Mark Boaz, Gerasimos J. Zaharatos, Phumla Adesanya, Daniel Dugin, Angela Lombardo, Martin Ho, Patricia E. Fast, Laura Seamons, Ba Lei, Arlene Hurley, Eddy Sayeed, Yaoxing Huang, Michael C. Keefer, Sarah J. Schlesinger, Josephine H. Cox, David D. Ho, Jill Gilmour, Soe Than
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8816 (2010)
PLoS ONE
PLoS ONE
Background We conducted a Phase I dose-escalation trial of ADMVA, a Clade-B'/C-based HIV-1 candidate vaccine expressing env, gag, pol, nef, and tat in a modified vaccinia Ankara viral vector. Sequences were derived from a prevalent circulating HIV-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::968837c617b89966c258a5c9cc1a0f12
http://europepmc.org/articles/PMC2810329?pdf=render
http://europepmc.org/articles/PMC2810329?pdf=render
Autor:
Jill Gilmour, Soe Than, Daniel Dugin, Laura Seamons, Arlene Hurley, Carol Smith, Yang Song, Lorna Clark, Angela Lombardo, Eddy Sayeed, C. Schmidt, Len Dally, David D. Ho, Sarah J. Schlesinger, Michael C. Keefer, Yaoxing Huang, Catherine A. Bunce, Zhiwei Chen, Sandhya Vasan, Martin Ho, Mark Boaz, Martin Markowitz, Josephine H. Cox, Dilbinder K. Gill, Patricia E. Fast, Rosanne Boyle, Phumla Adesanya
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8617 (2010)
PLoS ONE
PLoS ONE
Background We conducted a Phase I dose escalation trial of ADVAX, a DNA-based candidate HIV-1 vaccine expressing Clade C/B' env, gag, pol, nef, and tat genes. Sequences were derived from a prevalent circulating recombinant form in Yunnan, China, an a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b6d0b6adb9df2cc99cfa0ae3f17f203
http://hdl.handle.net/10044/1/24967
http://hdl.handle.net/10044/1/24967
Autor:
Patricia E. Fast, Jill Gilmour, David D. Ho, C. Schmidt, J Andersen, Sarah J. Schlesinger, Sandhya Vasan, Marina Caskey, Lorna Clark, Mar Boente-Carrera, Tony Tarragona, Robert M. Bernard, Arlene Hurley, Roselle Vittorino, David F. Gardiner, Carol Smith, Len Dally, Yaoxing Huang, Drew Hannaman, Harriet Park, Daniel Dugin, Eddy Sayeed, Josephine H. Cox, Dilbinder K. Gill, Hannah Cheeseman
Publikováno v:
Retrovirology, Vol 6, Iss Suppl 3, p O31 (2009)
Retrovirology
Retrovirology
Open Access Oral presentation OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers S Vasan*1, A Hurley1, SJ Schlesinger1, D Hannaman2, DF Gardiner1, DP Dugin1, MM Boente-Car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393f4f027858c9f4cab0970f0e0e373f
https://doaj.org/article/8b4b46b570484d6385665d7236a1c870
https://doaj.org/article/8b4b46b570484d6385665d7236a1c870